Sinopharm
1099.HK
#2088
Rank
HK$57.35 B
Marketcap
HK$18.38
Share price
-0.22%
Change (1 day)
-8.26%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Sinopharm (1099.HK) - Total debt

Total debt on the balance sheet as of December 2023 : HK$81.18 Billion

According to Sinopharm's latest financial reports the company's total debt is HK$81.18 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Sinopharm - Total debt on balance sheet (from 2008 to 2023)

Total debt by year

Year Total debt Change
2023-12-31HK$81.52 B3.41%
2022-12-31HK$78.83 B-5.77%
2021-12-31HK$83.66 B2.72%
2020-12-31HK$81.44 B32.5%
2019-12-31HK$61.47 B-2.03%
2018-12-31HK$62.74 B40.29%
2017-12-31HK$44.72 B19.56%
2016-12-31HK$37.40 B8%
2015-12-31HK$34.63 B-6.13%
2014-12-31HK$36.89 B14.54%
2013-12-31HK$32.21 B60.55%
2012-12-31HK$20.06 B17.24%
2011-12-31HK$17.11 B323.34%
2010-12-31HK$4.04 B107.21%
2009-12-31HK$1.95 B5.27%
2008-12-31HK$1.85 B-25.24%
2007-12-31HK$2.47 B32.21%
2006-12-31HK$1.87 B